These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22360790)

  • 41. Library fingerprints: a novel approach to the screening of virtual libraries.
    Klon AE; Diller DJ
    J Chem Inf Model; 2007; 47(4):1354-65. PubMed ID: 17595072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.
    Cosconati S; Marinelli L; La Motta C; Sartini S; Da Settimo F; Olson AJ; Novellino E
    J Med Chem; 2009 Sep; 52(18):5578-81. PubMed ID: 19719141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive comparison of ligand-based virtual screening tools against the DUD data set reveals limitations of current 3D methods.
    Venkatraman V; Pérez-Nueno VI; Mavridis L; Ritchie DW
    J Chem Inf Model; 2010 Dec; 50(12):2079-93. PubMed ID: 21090728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naïve Bayes classification using 2D pharmacophore feature triplet vectors.
    Watson P
    J Chem Inf Model; 2008 Jan; 48(1):166-78. PubMed ID: 18183968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementing relevance feedback in ligand-based virtual screening using Bayesian inference network.
    Abdo A; Salim N; Ahmed A
    J Biomol Screen; 2011 Oct; 16(9):1081-8. PubMed ID: 21862688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of virtual high-throughput screening methods for the identification of phosphodiesterase-5 inhibitors.
    Niinivehmas SP; Virtanen SI; Lehtonen JV; Postila PA; Pentikäinen OT
    J Chem Inf Model; 2011 Jun; 51(6):1353-63. PubMed ID: 21591817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virtual screening data fusion using both structure- and ligand-based methods.
    Svensson F; Karlén A; Sköld C
    J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Large-scale learning of structure-activity relationships using a linear support vector machine and problem-specific metrics.
    Hinselmann G; Rosenbaum L; Jahn A; Fechner N; Ostermann C; Zell A
    J Chem Inf Model; 2011 Feb; 51(2):203-13. PubMed ID: 21207929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
    Ebalunode JO; Zheng W; Tropsha A
    Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Introduction of an information-theoretic method to predict recovery rates of active compounds for Bayesian in silico screening: theory and screening trials.
    Vogt M; Bajorath J
    J Chem Inf Model; 2007; 47(2):337-41. PubMed ID: 17302401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research progress of virtual screening aided drug discovery].
    Liu AL; Du GH
    Yao Xue Xue Bao; 2009 Jun; 44(6):566-70. PubMed ID: 19806883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring.
    Sastry GM; Dixon SL; Sherman W
    J Chem Inf Model; 2011 Oct; 51(10):2455-66. PubMed ID: 21870862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
    Ren JX; Li LL; Zheng RL; Xie HZ; Cao ZX; Feng S; Pan YL; Chen X; Wei YQ; Yang SY
    J Chem Inf Model; 2011 Jun; 51(6):1364-75. PubMed ID: 21618971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation.
    Geppert H; Vogt M; Bajorath J
    J Chem Inf Model; 2010 Feb; 50(2):205-16. PubMed ID: 20088575
    [No Abstract]   [Full Text] [Related]  

  • 55. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening.
    Liu X; Jiang H; Li H
    J Chem Inf Model; 2011 Sep; 51(9):2372-85. PubMed ID: 21819157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using consensus-shape clustering to identify promiscuous ligands and protein targets and to choose the right query for shape-based virtual screening.
    Pérez-Nueno VI; Ritchie DW
    J Chem Inf Model; 2011 Jun; 51(6):1233-48. PubMed ID: 21604699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
    Park H; Bhattarai BR; Ham SW; Cho H
    Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential.
    Li R; Stumpfe D; Vogt M; Geppert H; Bajorath J
    J Chem Inf Model; 2011 Oct; 51(10):2507-14. PubMed ID: 21955025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PubChem BioAssays as a data source for predictive models.
    Chen B; Wild DJ
    J Mol Graph Model; 2010 Jan; 28(5):420-6. PubMed ID: 19897391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.